China today approved a vaccine against the new coronavirus, for internal use in the People’s Liberation Army, the country’s armed forces, after positive results in clinical trials.
The vaccine was created by the Military Scientific Institute and the Chinese biopharmaceutical company CanSino Biologics, according to a statement from this firm, which is based in the port city of Tianjin, northeast China.
The new vaccine uses the molecular cloning of covid-19, a genetic engineering technique also known as recombinant DNA, and was approved for “exclusive use by the Chinese military” on June 25 by the Central Military Commission, according to local media.
Approval is valid for one year.
The CanSino vaccine has gone through phases one and two of tests, which indicated that it has “the potential to prevent diseases caused by Sars-Cov-2”, the virus that causes covid-19, CanSino said in a statement.
Almost 150 vaccines for covid-19 are being developed by scientists around the world. Seven vaccine candidates developed by Chinese companies are undergoing clinical trials in China.